On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
The African Centre for Biodiversity (ACB) is extremely alarmed to learn that three genetically modified maize varieties developed by Corteva (new name of the Dow-DuPont merged entity) to withstand the application of the dangerous 2,4-D herbicide have been approved for general release by the Executiv
We, the undersigned civil society organisations from Africa and around the world, denounce the release of genetically modified (GM) “male-sterile” mosquitoes in Burkina Faso. The GM mosquitoes were released in the village of Bana on 1 July 2019 by the Target Malaria research consortium.[i]
The African Centre for Biodiversity (ACB) has lodged an objection against Pioneer Hi-Bred’s application for field trials of RNAi /gene silencing (DP-566113-9) GM maize, since the risks to the health of the environment and humans is, as yet, unknown.
African farmers are demanding that Lynas cease using their images in his GMO promotionals; Lynas’s mischief-making may have triggered Tanzania’s ending of GMO field trials. Report: Claire Robinson, GMWatch and Mariam Mayet, African Centre for Biodiversity
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.